Launching Astepro Allergy in the US following a successful Rx-to-OTC switch helped Bayer Consumer Health’s Allergy & Cold category post a double-digit rise in sales in the third quarter.
Allergy & Cold sales jumped by 32.6% to €342m ($344m) in Q3 as the gain delivered by Astepro was bolstered...







